Zhejiang CONBA Pharmaceutical Co Ltd Net Asset Quality Index
Zhejiang CONBA Pharmaceutical Co Ltd net asset quality index. Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Net Asset Quality Index of 72.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.22 Billion minus total liabilities of CN¥2.85 Billion yields net assets of CN¥7.37 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is Zhejiang CONBA Pharmaceutical Co Ltd's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhejiang CONBA Pharmaceutical Co Ltd (2001–2025)
Net asset quality index of Zhejiang CONBA Pharmaceutical Co Ltd from 2001 to 2025. This chart shows how Zhejiang CONBA Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 25 annual periods from 2001 to 2025. As of March 2026, the index stands at 72.1%, representing net assets of CN¥7.37 Billion against total assets of CN¥10.22 Billion CNY. Check 600572 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Zhejiang CONBA Pharmaceutical Co Ltd Net Asset Quality Index by Year (2001–2025)
Zhejiang CONBA Pharmaceutical Co Ltd net asset quality index by year from 2001 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 600572 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.6% | CN¥7.15 Billion | CN¥9.98 Billion | CN¥2.83 Billion | ▲ +1.8 pp |
| 2024 | 69.8% | CN¥6.91 Billion | CN¥9.90 Billion | CN¥2.99 Billion | ▲ +4.4 pp |
| 2023 | 65.4% | CN¥7.35 Billion | CN¥11.24 Billion | CN¥3.89 Billion | ▼ -1.6 pp |
| 2022 | 67.0% | CN¥7.32 Billion | CN¥10.93 Billion | CN¥3.61 Billion | ▼ -1.5 pp |
| 2021 | 68.5% | CN¥7.39 Billion | CN¥10.79 Billion | CN¥3.40 Billion | ▲ +10.8 pp |
| 2020 | 57.7% | CN¥5.35 Billion | CN¥9.28 Billion | CN¥3.93 Billion | ▲ +7.5 pp |
| 2019 | 50.1% | CN¥4.94 Billion | CN¥9.86 Billion | CN¥4.92 Billion | ▼ -3.9 pp |
| 2018 | 54.1% | CN¥5.79 Billion | CN¥10.71 Billion | CN¥4.92 Billion | ▼ -8.0 pp |
| 2017 | 62.0% | CN¥5.84 Billion | CN¥9.42 Billion | CN¥3.58 Billion | ▲ +9.2 pp |
| 2016 | 52.8% | CN¥4.49 Billion | CN¥8.50 Billion | CN¥4.01 Billion | ▲ +5.1 pp |
| 2015 | 47.7% | CN¥4.57 Billion | CN¥9.57 Billion | CN¥5.00 Billion | ▼ -5.8 pp |
| 2014 | 53.5% | CN¥3.37 Billion | CN¥6.30 Billion | CN¥2.93 Billion | ▼ -4.7 pp |
| 2013 | 58.2% | CN¥2.59 Billion | CN¥4.45 Billion | CN¥1.86 Billion | ▲ +4.4 pp |
| 2012 | 53.8% | CN¥2.44 Billion | CN¥4.54 Billion | CN¥2.10 Billion | ▼ -0.7 pp |
| 2011 | 54.5% | CN¥1.61 Billion | CN¥2.96 Billion | CN¥1.35 Billion | ▼ -15.2 pp |
| 2010 | 69.7% | CN¥1.72 Billion | CN¥2.46 Billion | CN¥747.34 Million | ▲ +10.2 pp |
| 2009 | 59.5% | CN¥1.15 Billion | CN¥1.93 Billion | CN¥780.76 Million | ▲ +0.9 pp |
| 2008 | 58.6% | CN¥919.66 Million | CN¥1.57 Billion | CN¥649.60 Million | ▲ +3.4 pp |
| 2007 | 55.2% | CN¥854.74 Million | CN¥1.55 Billion | CN¥693.32 Million | ▲ +5.2 pp |
| 2006 | 50.0% | CN¥627.66 Million | CN¥1.26 Billion | CN¥628.20 Million | ▼ -1.5 pp |
| 2005 | 51.5% | CN¥595.08 Million | CN¥1.16 Billion | CN¥560.55 Million | ▼ -6.1 pp |
| 2004 | 57.6% | CN¥565.05 Million | CN¥981.41 Million | CN¥416.37 Million | ▲ +16.4 pp |
| 2003 | 41.2% | CN¥239.44 Million | CN¥581.65 Million | CN¥342.22 Million | ▼ -2.2 pp |
| 2002 | 43.4% | CN¥200.75 Million | CN¥462.63 Million | CN¥261.88 Million | ▲ +2.8 pp |
| 2001 | 40.6% | CN¥181.89 Million | CN¥447.63 Million | CN¥265.74 Million | — |